Divya Teli

758 total citations · 1 hit paper
21 papers, 514 citations indexed

About

Divya Teli is a scholar working on Computational Theory and Mathematics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Divya Teli has authored 21 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Computational Theory and Mathematics, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Divya Teli's work include Computational Drug Discovery Methods (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Synthesis and biological activity (4 papers). Divya Teli is often cited by papers focused on Computational Drug Discovery Methods (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Synthesis and biological activity (4 papers). Divya Teli collaborates with scholars based in India, Australia and United Kingdom. Divya Teli's co-authors include Mahesh T. Chhabria, Vivek P. Chavda, Mamta B. Shah, Vasso Apostolopoulos, Joanna Bojarska, Pankti C. Balar, Anuradha Gajjar, Ashish M. Kanhed, Dushyant V. Patel and Mange Ram Yadav and has published in prestigious journals such as Molecules, International Journal of Biological Macromolecules and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Divya Teli

19 papers receiving 507 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

2022 127 citations Vivek P. Chavda, Divya Teli et al. Molecules profile →

Peers

Divya Teli

CTM

MB

PHARM

OC

EDM

Sneha B. Bansode India

Manne Munikumar India

Opeyemi Iwaloye Nigeria

Gideon Ampoma Gyebi Nigeria

James H. Zothantluanga India

Shovonlal Bhowmick India

Sarvesh Sabarathinam India

Sharuk L. Khan India

Mustofa Mustofa Indonesia

Sanjay G. Walode India

Sneha B. Bansode India

Divya Teli

178 ×1.0

CTM

170 ×1.1

MB

47 ×0.4

PHARM

44 ×0.4

OC

78 ×0.9

EDM

Citations per year, relative to Divya Teli Divya Teli (= 1×) peers Sneha B. Bansode

Countries citing papers authored by Divya Teli

Since Specialization

Citations

This map shows the geographic impact of Divya Teli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Divya Teli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Divya Teli more than expected).

Fields of papers citing papers by Divya Teli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Divya Teli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Divya Teli. The network helps show where Divya Teli may publish in the future.

Co-authorship network of co-authors of Divya Teli

This figure shows the co-authorship network connecting the top 25 collaborators of Divya Teli. A scholar is included among the top collaborators of Divya Teli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Divya Teli. Divya Teli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Teli, Divya, et al.. (2024). Nature meets technology: Harnessing nanotechnology to unleash the power of phytochemicals. 5(2). 200139–200139. 20 indexed citations

2.

Chavda, Vivek P., Divya Teli, Pankti C. Balar, et al.. (2024). Self-assembled peptide hydrogels for the treatment of diabetes and associated complications. Colloids and Surfaces B Biointerfaces. 235. 113761–113761. 5 indexed citations

3.

Teli, Divya, et al.. (2024). Andrographolide: A Review on Experimental Clinical Trials and Applications. 55–72.

4.

Chavda, Vivek P., et al.. (2024). Propolis in the management of cardiovascular disease. International Journal of Biological Macromolecules. 266(Pt 2). 131219–131219. 10 indexed citations

5.

Teli, Divya, Mehul R. Chorawala, Abhilasha Sharma, et al.. (2023). Apolipoprotein E3 functionalized lipid-drug conjugated nanoparticles of Levetiracetam for enhanced delivery to the brain: In-vitro cell line studies and in-vivo study. International Journal of Biological Macromolecules. 254(Pt 2). 127799–127799. 7 indexed citations

6.

Metwaly, Ahmed M., et al.. (2023). Discovery of Anti‐Breast Cancer Thiophene Sulfonamide Derivatives: Design, Synthesis, Molecular Docking against EGFR, MM‐PBSA, MD Simulations, ADME/Tox, and in vitro Studies. ChemistrySelect. 8(27). 2 indexed citations

7.

Chavda, Vivek P., Pankti C. Balar, Divya Teli, et al.. (2023). Antibody–Biopolymer Conjugates in Oncology: A Review. Molecules. 28(6). 2605–2605. 15 indexed citations

8.

Teli, Divya, et al.. (2023). Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations. ChemistrySelect. 8(34). 6 indexed citations

9.

Teli, Divya & Anuradha Gajjar. (2023). Glycogen synthase kinase-3: A potential target for diabetes. Bioorganic & Medicinal Chemistry. 92. 117406–117406. 29 indexed citations

10.

Chavda, Vivek P., et al.. (2023). Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules. 28(5). 2332–2332. 10 indexed citations

11.

Chavda, Vivek P., et al.. (2023). Propolis and Their Active Constituents for Chronic Diseases. Biomedicines. 11(2). 259–259. 24 indexed citations

12.

Teli, Divya, et al.. (2023). NOVEL TOPICAL ANTI-AGING HERBAL COMPOSITION. International Journal of Current Pharmaceutical Research. 42–46.

13.

Teli, Divya, et al.. (2023). Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites. 13(2). 309–309. 22 indexed citations

14.

Teli, Divya, et al.. (2022). Fragment-based design of SARS-CoV-2 Mpro inhibitors. Structural Chemistry. 33(6). 2155–2168. 9 indexed citations

15.

Teli, Divya, Mamta B. Shah, & Mahesh T. Chhabria. (2021). In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19. Frontiers in Molecular Biosciences. 7. 599079–599079. 105 indexed citations

16.

Patel, Dushyant V., et al.. (2021). Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents. Journal of Biomolecular Structure and Dynamics. 40(20). 10278–10299. 12 indexed citations

17.

Patel, Dushyant V., Ashish M. Kanhed, Divya Teli, et al.. (2020). Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorganic Chemistry. 101. 103977–103977. 35 indexed citations

18.

Kanhed, Ashish M., et al.. (2020). Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach. Molecular Diversity. 25(1). 383–401. 52 indexed citations

19.

Patel, Dushyant V., Divya Teli, Ashish M. Kanhed, et al.. (2020). Identification of Potential Mpro Inhibitors for the Treatment of COVID-19 by Targeted Covalent Inhibition. 6(2). 58–77. 2 indexed citations

20.

Patel, Dushyant V., Ashish M. Kanhed, Divya Teli, et al.. (2020). Further Studies on Triazinoindoles as Potential Novel Multitarget-Directed Anti-Alzheimer’s Agents. ACS Chemical Neuroscience. 11(21). 3557–3574. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact